Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has led to significant morbidity and mortality …

Background The recent emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has resulted in a rapid proliferation of serologic assays. However, little is …

In the race to contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
efficient detection and triage of infected patients must rely on rapid and reliable testing. In …

The diagnosis of COVID‐19 requires integration of clinical and laboratory data. Severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central …

The ongoing coronavirus disease (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) poses a severe threat to human health and the …

Methods: The Indian Council of Medical Research (ICMR)-National Institute of Virology
(NIV), Pune, established screening as well as confirmatory assays for SARS-CoV-2. A total …

Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume …

With an almost unremittent progression of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infections all around the world, there is a compelling need to introduce rapid …

Multiple laboratory-developed tests (LDTs) and commercially available assays have
emerged to meet diagnostic needs related to the severe acute respiratory syndrome …

Background COVID-19 has put enormous demand on laboratory infrastructure and required
an unprecedented rapid scale-up of testing capacity for its causative agent, SARS-CoV-2, at …